13F Holdings
中文EN

ATRC AtriCure, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1323885 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.8%
TTM net income YoY151.7%
TTM EPS YoY150.8%
Revenue 3-yr CAGR15.7%
Net income 3-yr CAGR—

Margins

Gross margin76.7%
Operating margin2.9%
Net margin2.5%
FCF margin9.0%
EBITDA margin4.9%

Returns

ROE2.9%
ROA2.2%
ROIC (approx.)3.9%
Asset turnover0.87x

Leverage & solvency

Liabilities / assets25.7%
Debt / equity0.11x
Current ratio4.33x
Interest coverage2.95x

Cash quality & payout

Operating cash flow / net income4.61x
Accruals ratio-7.9%
Payout ratio—
Capex / revenue2.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$534.53M$465.31M$399.25M$330.38M$274.33M
Cost of revenue$133.75M$117.78M$98.88M$84.44M$68.47M
Gross profit$400.78M$347.52M$300.37M$245.94M$205.86M
R&D expense$99.21M$96.18M$73.92M$57.34M$48.51M
SG&A expense$311.02M$291.36M$253.14M$231.27M$204.65M
Operating income-$9.45M-$40.01M-$26.68M-$42.67M$55.20M
Interest expense$5.88M$6.41M$6.92M$4.99M$4.92M
Pretax income-$10.16M-$43.67M-$29.85M-$46.20M$50.39M
Income tax$1.28M$1.02M$591,000$268,000$188,000
Net income-$11.45M-$44.70M-$30.44M-$46.47M$50.20M
EBITDA$2.64M-$28.80M-$17.22M-$34.61M$62.74M
EPS (basic)-0.24-0.95-0.66-1.021.11
EPS (diluted)-0.24-0.95-0.66-1.021.09
Weighted avg. shares (diluted)47.75M46.97M46.31M45.74M46.04M
Balance sheet
Cash & equivalents$167.43M$122.72M$84.31M$58.10M$43.65M
Short-term investments—$0$52.98M$63.01M$75.44M
Receivables$66.65M$60.34M$52.50M$42.69M$33.02M
Inventory$78.49M$75.33M$67.90M$45.93M$38.96M
Current assets$322.52M$267.83M$266.25M$215.21M$196.08M
PP&E, net$39.12M$41.66M$42.44M$38.83M$31.41M
Goodwill$234.78M$234.78M$234.78M$234.78M$234.78M
Intangibles$48.03M$56.47M$63.99M$39.34M$42.99M
Total assets$654.18M$609.33M$613.93M$585.45M$615.31M
Current liabilities$81.52M$73.42M$74.57M$58.39M$56.45M
Short-term debt—$2.81M$2.53M$5.47M—
Long-term debt$61.87M$61.87M$60.59M$56.83M$59.74M
Total debt$61.87M$64.67M$63.13M$62.31M$59.74M
Total liabilities$162.24M$148.36M$147.76M$128.69M$131.56M
Shareholders' equity$491.94M$460.97M$466.17M$456.75M$483.76M
Net debt-$105.56M-$58.05M-$21.18M$4.21M$16.09M
Shares outstanding49.79M48.87M47.53M46.56M46.02M
Cash flow statement
Operating cash flow$57.33M$12.20M$4.48M-$22.14M-$13.78M
Capital expenditure$9.05M$11.46M$12.00M$16.88M$9.75M
Free cash flow$48.28M$745,000-$7.51M-$39.02M-$23.53M
Investing cash flow-$14.55M$30.23M$21.82M$44.01M$23.50M
Financing cash flow$1.18M-$3.60M-$32,000-$7.06M-$7.64M
Depreciation & amortization$12.09M$11.21M$9.46M$8.06M$7.53M
Stock-based compensation$44.69M$40.41M$35.73M$28.77M$28.08M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.